StockNews.com Begins Coverage on Titan Pharmaceuticals (NASDAQ:TTNP)

StockNews.com assumed coverage on shares of Titan Pharmaceuticals (NASDAQ:TTNP – Get Rating) in a research note released on Friday. The firm issued a sell rating on the specialty pharmaceutical company’s stock. Titan Pharmaceuticals Stock Performance NASDAQ:TTNP opened at $0.76 on Friday. The stock’s fifty day moving average is $0.84 and its 200 day moving average […]

Related Keywords

Davide Lazar , ,Titan Pharmaceuticals ,News Ratings For Titan Pharmaceuticals Daily ,Virtu Financial ,Titan Pharmaceuticals Inc ,Renaissance Technologies ,Titan Pharmaceuticals Company Profile ,Millennium Management ,Nasdaq ,Institutional Investors Weigh In On Titan Pharmaceuticals ,Titan Pharmaceuticals Stock Performance ,Investment Advisers ,Get Rating ,Street Corp ,Titan Pharmaceuticals Daily ,Nasdaq Ttnp ,Ttnp ,Medical ,Initiated Coverage ,Stocknews Com ,